TROG 10.02 (RAPID)
Primary sponsor: OCOG (Ontario Clinical Oncology Group)
Collaborating groups: TROG
Title
A Randomised Trial of Accelerated Partial Breast Irradiation
Summary
Doctors are always looking for better ways to treat people with breast cancer. Partial breast irradiation (in comparison to whole breast irradiation) exposes less of the body to a high dose of radiation. Also, because a smaller area is treated, the size of each radiation treatment can be larger. This means that partial breast irradiation can be completed in 1 week (2 treatments per day over 5 days for a total of 10 treatments) instead of up to 6 weeks required for whole breast irradiation.
This study compares partial breast irradiation to whole breast irradiation to see if it is effective as whole breast irradiation at preventing breast cancer recurrence, if the side-effects are different, if it is more convenient for women and if it has different effects on the quality of life of women receiving radiation after breast conserving surgery.
Final accrual
2128
Trial Status
Closed to accrual, July 2011
Trial chairpersons
International: Dr Tim Whelan and Dr Ivo Olivotto (OCOG)
Australian: Prof Boon Chua, Director of Cancer and Haematology Services at UNSW and Prince of Wales Hospital, Sydney
Trial contact
Rebecca Montgomery
TROG Trial Coordinating Centre
Phone: +61 2 4014 3910
Email: rebecca.montgomery@trog.com.au
Further information
TROG trial 10.02 on Australian Cancer Trials website
Trial resources for TROG members
TROG 10.02 member page
|